Figure 1

Flow diagram of the study design. All recipients of the Moderna mRNA vaccine against COVID-19 at a single mass vaccination center were enrolled in the study. Detailed information on the occurrence of acute adverse events at the site of the center was evaluated after stratification by age group, sex, and the time of vaccination.